User menu

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.

Bibliographic reference Delforge, Michel ; Selleslag, Dominik ; Beguin, Yves ; Triffet, Agnès ; Mineur, Philippe ; et. al. Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.. In: Leukemia Research, Vol. 38, no. 5, p. 557-563 (2014)
Permanent URL http://hdl.handle.net/2078.1/146140